Clinical Updates of mRNA-1345, Moderna’s Prophylactic Vaccine for RSV

Time: 2:45 pm
day: Day One Morning

Details:

  • Learn how an mRNA vaccine against RSV encoding a pre-fusion F glycoprotein, can lead to a superior neutralizing antibody response compared to the post-fusion state
  • Phase 1 data to show promising results of RSV prevention in older adults

Speakers: